About the HIV Research Program

What We Do:

Cover of document
NIDA HRP Brochure (PDF 248 KB)

NIDA's HIV Research Program (HRP) supports the development, planning, and coordination of high priority research at the intersection HIV/AIDS and substance use disorders within NIDA, NIH Institutes and other DHHS agencies.


NIDA created its AIDS Research Program in 2004 to explore the complex intersection of HIV/AIDS and substance use disorders. The program includes research into the increased vulnerability to the immune system brought by chronic exposure to addictive substances; the HIV risks associated with injection drug use; and prevention of risky behaviors linked to impaired judgment that have historically been part of the HIV transmission cycle.

Nearly two decades later, the AIDS Research Program has become the HIV Research Program. In this time it has grown into a substantial portion of NIDA’s mission, resources, and research portfolio, overseeing interdisciplinary initiatives and critical funding opportunities that have advanced the field.

HRP Research Findings Thumbnail
Research Findings Timeline (PDF 930KB)

To highlight our accomplishments,  NIDA has created two graphic timelines - one timeline identifies some of our high impact research findings related to the crossroads of HIV and substance use (PDF, 930 KB), and the other identifies key policy and outreach milestones (PDF, 903KB). These timelines not only reveal a history of program accomplishments but also forecast future achievements in research.

NIDA HIV Research Priority Areas

To support research at the intersection of substance use, HIV, and related comorbidities and generate evidence-based strategies to improve individual and public health:

HRP Policy and Outreach Timeline thumbnail
Policy & Outreach Timeline (PDF 903KB)
  1. Prevent new infections and transmission of HIV among people who use drugs and their sexual and/or injection partners.
  2. Increase understanding of etiology, pathogenesis, spread, and persistence of HIV/AIDS among people who use drugs.
  3. Address comorbidities and improve health outcomes among people living with HIV who use drugs. 
  4. Accelerate scientific discoveries in HIV/AIDS and substance use research.

See also:

Funding Priorities

Research Resources

Training Opportunities


Additional Links of Interest